Chronix Biomedical and Hemispherx Biopharma Jointly File Patent Application for a Blood Test for Chronic Fatigue Syndrome (CFS) Chronix Technology Focuses on Changes to CFS Patients' DNA Hemispherx and Chronix Plan Studies to Validate Technology as a Potential Diagnostic Test for CFS SAN JOSE, Calif., March 3, 2011...